Mates Sharon (CIK 1585699) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-04-02). Recent activity: Sell ITCI (945,235 shares), Sell ITCI (190,000 shares), Sell ITCI (190,000 shares), Buy ITCI (190,000 shares), Buy ITCI (40,712 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Sell | 945,235 | $124.8M |
| 2025-04-02 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Sell | 190,000 | $25.1M |
| 2025-03-31 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Sell | 190,000 | $0 |
| 2025-03-31 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Buy | 190,000 | $0 |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Buy | 40,712 | $0 |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Sell | 19,848 | $2.6M |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Buy | 20,566 | $0 |
| 2025-03-10 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Sell | 10,129 | $1.3M |
| 2025-03-04 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Buy | 34,969 | $0 |
| 2025-03-04 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Sell | 16,978 | $2.2M |
| 2025-02-04 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Buy | 30,847 | $0 |
| 2025-02-04 | Intra-Cellular Therapies, Inc. (ITCI) | Chairman and CEO | Sell | 15,233 | $1.9M |
Source: SEC Form 4 filings · as of 2025-04-02